1. Home
  2. WSHP vs EMBC Comparison

WSHP vs EMBC Comparison

Compare WSHP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WSHP

WeShop Holdings Limited Class A Ordinary Shares

N/A

Current Price

$12.90

Market Cap

487.8M

Sector

N/A

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.62

Market Cap

524.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSHP
EMBC
Founded
2021
1924
Country
British Virgin Islands
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.8M
524.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WSHP
EMBC
Price
$12.90
$9.62
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
1.2M
730.5K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
N/A
6.25%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.99
Revenue Growth
N/A
N/A
52 Week Low
$4.95
$8.47
52 Week High
$250.00
$15.55

Technical Indicators

Market Signals
Indicator
WSHP
EMBC
Relative Strength Index (RSI) 53.05 57.67
Support Level $4.95 $9.55
Resistance Level $117.73 $10.90
Average True Range (ATR) 3.39 0.34
MACD 2.12 0.14
Stochastic Oscillator 22.97 78.42

Price Performance

Historical Comparison
WSHP
EMBC

About WSHP WeShop Holdings Limited Class A Ordinary Shares

WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the Company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: